Stockreport

Inovio Pharmaceuticals: The Dilution Continues [Seeking Alpha]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF INO's latest try at bringing a treatment to market is INO-3107, for which it expects to submit a BLA in the second half of 2024. Potential market size if the BLA is s [Read more]